Insights into the hepatocellular carcinoma patient journey: Results of the first global quality of life survey
from Future Oncology
The aim of this study was to better understand the hepatocellular carcinoma (HCC) patient journey, we conducted a patient survey across 13 countries. The survey included closed- and open-ended questions developed using an iterative process to gather information on demographics, diagnosis and treatment. Patients self-selected or were directed to the online survey by their doctor.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063